A Five Autophagy-Related Long Non-Coding RNA Prognostic Model for Patients with Lung Adenocarcinoma

References

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. doi:10.3322/caac.20107
   PubMed Web of Science ®Google Scholar
• Sholl LM. The molecular pathology of lung cancer. Surg Pathol Clin. 2016;9(3):353–378. doi:10.1016/j.path.2016.04.003
   PubMedGoogle Scholar
• Hsu HC, Li SJ, Chen CY, Chen MF. Eicosapentaenoic acid protects cardiomyoblasts from lipotoxicity in an autophagy-dependent manner. Cell Biol Toxicol. 2018;34(3):177–189. doi:10.1007/s10565-017-9406-9
   PubMed Web of Science ®Google Scholar
• Levine B, Kroemer G. Biological functions of autophagy genes: a disease perspective. Cell. 2019;176(1–2):11–42. doi:10.1016/j.cell.2018.09.048
   PubMed Web of Science ®Google Scholar
• Tsai WT, Lo YC, Wu MS, et al. Mycotoxin patulin suppresses innate immune responses by mitochondrial dysfunction and p62/Sequestosome-1-dependent mitophagy. J Biol Chem. 2016;291(37):19299–19311. doi:10.1074/jbc.M115.686683
   PubMed Web of Science ®Google Scholar
• Mah LY, Ryan KM. Autophagy and cancer. Cold Spring Harb Perspect Biol. 2012;4(1):a008821. doi:10.1101/cshperspect.a008821
   PubMed Web of Science ®Google Scholar
• Goldberg SB, Supko JG, Neal JW, et al. A Phase I study of erlotinib and hydroxychloroquine in advanced non-small-cell lung cancer. J Thorac Oncol. 2012;7(10):1602–1608. doi:10.1097/JTO.0b013e318262de4a
   PubMed Web of Science ®Google Scholar
• Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77(15):3965–3981. doi:10.1158/0008-5472.CAN-16-2634
   PubMed Web of Science ®Google Scholar
• Liu Y, Sharma S, Watabe K. Roles of lncRNA in breast cancer. Front Biosci. 2015;7(1):94–108. doi:10.2741/s427
   Google Scholar
• Thin KZ, Liu X, Feng X, Raveendran S, Tu JC. LncRNA-DANCR: a valuable cancer related long non-coding RNA for human cancers. Pathol Res Pract. 2018;214(6):801–805. doi:10.1016/j.prp.2018.04.003
   PubMed Web of Science ®Google Scholar
• Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer. 2011;10(1):38. doi:10.1186/1476-4598-10-38
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102. doi:10.1093/nar/gkx247
   PubMed Web of Science ®Google Scholar
• Shintani T, Klionsky DJ. Autophagy in health and disease: a double-edged sword. Science. 2004;306(5698):990–995. doi:10.1126/science.1099993
   PubMed Web of Science ®Google Scholar
• White E, DiPaola RS. The double-edged sword of autophagy modulation in cancer. Clin Cancer Res. 2009;15(17):5308–5316. doi:10.1158/1078-0432.CCR-07-5023
   PubMed Web of Science ®Google Scholar
• Jin KT, Lu ZB, Lv JQ, Zhang JG. The role of long non-coding RNAs in mediating chemoresistance by modulating autophagy in cancer. RNA Biol. 2020;17(12):1727–1740. doi:10.1080/15476286.2020.1737787
   PubMed Web of Science ®Google Scholar
• Zeng L, Wang W, Chen Y, et al. A five-long non-coding RNA signature with the ability to predict overall survival of patients with lung adenocarcinoma. Exp Ther Med. 2019;18(6):4852–4864. doi:10.3892/etm.2019.8138
   PubMed Web of Science ®Google Scholar
• Jin D, Song Y, Chen Y, Zhang P. Identification of a seven-lncRNA immune risk signature and construction of a predictive nomogram for lung adenocarcinoma. Biomed Res Int. 2020;2020:7929132. doi:10.1155/2020/7929132
   PubMed Web of Science ®Google Scholar
• Wilson TR, Redmond KM, McLaughlin KM, et al. Procaspase 8 overexpression in non-small-cell lung cancer promotes apoptosis induced by FLIP silencing. Cell Death Differ. 2009;16(10):1352–1361. doi:10.1038/cdd.2009.76
   PubMed Web of Science ®Google Scholar
• Kaminskyy VO, Surova OV, Piskunova T, et al. Upregulation of c-FLIP-short in response to TRAIL promotes survival of NSCLC cells, which could be suppressed by inhibition of Ca2+/calmodulin signaling. Cell Death Dis. 2013;4(3):e522. doi:10.1038/cddis.2013.51
   PubMed Web of Science ®Google Scholar
• Chen J, Yuan ZH, Hou XH, Shi MH, Jiang R. LINC01116 promotes the proliferation and inhibits the apoptosis of gastric cancer cells. Eur Rev Med Pharmacol Sci. 2020;24(4):1807–1814. doi:10.26355/eurrev_202002_20358
   PubMed Web of Science ®Google Scholar
• Fang YN, Huang ZL, Li H, et al. LINC01116 promotes the progression of epithelial ovarian cancer via regulating cell apoptosis. Eur Rev Med Pharmacol Sci. 2018;22(16):5127–5133. doi:10.26355/eurrev_201808_15707
   PubMed Web of Science ®Google Scholar
• Su X, Zhang J, Luo X, et al. LncRNA LINC01116 promotes cancer cell proliferation, migration and invasion in gastric cancer by positively interacting with lncRNA CASC11. Onco Targets Ther. 2019;12:8117–8123. doi:10.2147/OTT.S208133
   PubMed Web of Science ®Google Scholar
• Wang T, Cao L, Dong X, et al. LINC01116 promotes tumor proliferation and neutrophil recruitment via DDX5-mediated regulation of IL-1beta in glioma cell. Cell Death Dis. 2020;11(5):302. doi:10.1038/s41419-020-2506-0
   PubMed Web of Science ®Google Scholar
• Wang H, Lu B, Ren S, et al. Long noncoding RNA LINC01116 contributes to gefitinib resistance in non-small cell lung cancer through regulating IFI44. Mol Ther Nucleic Acids. 2020;19:218–227. doi:10.1016/j.omtn.2019.10.039
   PubMedGoogle Scholar
• Ye J, Zhu J, Chen H, et al. A novel lncRNA-LINC01116 regulates tumorigenesis of glioma by targeting VEGFA. Int J Cancer. 2020;146(1):248–261. doi:10.1002/ijc.32483
   PubMed Web of Science ®Google Scholar
• Zeng L, Lyu X, Yuan J, et al. Long non-coding RNA LINC01116 is overexpressed in lung adenocarcinoma and promotes tumor proliferation and metastasis. Am J Transl Res. 2020;12(8):4302–4313.
   PubMed Web of Science ®Google Scholar
• Fan X, Sun Y, Guo X, He C, Han B, Sun X. Long non-coding RNA LINC01116 regulated miR-744-5p/SCN1B axis to exacerbate lung squamous cell carcinoma. Cancer Biomark. 2020;28(4):473–482. doi:10.3233/CBM-190945
   PubMed Web of Science ®Google Scholar
• Wang J, Gao J, Chen Q, et al. LncRNA LINC01116 contributes to cisplatin resistance in lung adenocarcinoma. Onco Targets Ther. 2020;13:9333–9348. doi:10.2147/OTT.S244879
   PubMed Web of Science ®Google Scholar
• Hao L, Zhou X, Liu S, et al. Elevated GAPDH expression is associated with the proliferation and invasion of lung and esophageal squamous cell carcinomas. Proteomics. 2015;15(17):3087–3100. doi:10.1002/pmic.201400577
   PubMed Web of Science ®Google Scholar
• Xu ML, Kim HJ, Kim SC, et al. Serum anti-GAPDH autoantibody levels reflect the severity of cervical lesions: a potential serum biomarker for cervical cancer screening. Oncol Lett. 2019;18(1):255–264. doi:10.3892/ol.2019.10326
   PubMed Web of Science ®Google Scholar
• Fan F, Huang Z, Chen Y. Integrated analysis of immune-related long noncoding RNAs as diagnostic biomarkers in psoriasis. PeerJ. 2021;9:e11018. doi:10.7717/peerj.11018
   PubMed Web of Science ®Google Scholar
• Tani H, Numajiri A, Aoki M, Umemura T, Nakazato T. Short-lived long noncoding RNAs as surrogate indicators for chemical stress in HepG2 cells and their degradation by nuclear RNases. Sci Rep. 2019;9(1):20299. doi:10.1038/s41598-019-56869-y
   PubMed Web of Science ®Google Scholar
• Kakumoto K, Ikeda J, Okada M, Morii E, Oneyama C. mLST8 promotes mTOR-mediated tumor progression. PLoS One. 2015;10(4):e0119015. doi:10.1371/journal.pone.0119015
   PubMed Web of Science ®Google Scholar
• Sapam TD, Velmurugan Ilavarasi A, Palaka BK, Elumalai E, Kanika ND, Ampasala DR. Identifying novel small molecule antagonists for mLST8 protein using computational approaches. J Recept Signal Transduct Res. 2018;38(1):1–11. doi:10.1080/10799893.2017.1387920
   PubMed Web of Science ®Google Scholar
• Xu Y, Huang Y, Weng L, et al. Effects of single-nucleotide polymorphisms in the mTORC1 pathway on the risk of brain metastasis in patients with non-small cell lung cancer. J Cancer Res Clin Oncol. 2020;146(1):273–285. doi:10.1007/s00432-019-03059-y
   PubMed Web of Science ®Google Scholar
• Komarov PG, Komarova EA, Kondratov RV, et al. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science. 1999;285(5434):1733–1737. doi:10.1126/science.285.5434.1733
   PubMed Web of Science ®Google Scholar
• Nikoletopoulou V, Markaki M, Palikaras K, Tavernarakis N. Crosstalk between apoptosis, necrosis and autophagy. Biochim Biophys Acta. 2013;1833(12):3448–3459. doi:10.1016/j.bbamcr.2013.06.001
   PubMed Web of Science ®Google Scholar
• Yu H, Jove R. The STATs of cancer–new molecular targets come of age. Nat Rev Cancer. 2004;4(2):97–105. doi:10.1038/nrc1275
   PubMed Web of Science ®Google Scholar
• Sun Y, Han Y, Wang X, et al. Correlation of EGFR Del 19 with Fn14/JAK/STAT signaling molecules in non-small cell lung cancer. Oncol Rep. 2016;36(2):1030–1040. doi:10.3892/or.2016.4905
   PubMed Web of Science ®Google Scholar